Emergent BioSolutions, Inc. (NYSE: EBS) specializes in the protection and enhancement of life through developing and manufacturing vaccines and therapeutics. These are supplied to purchasers and healthcare providers to be used in the prevention and treatment of disease. The company’s products, both marketed and investigational, are designed to target infectious diseases, oncology and autoimmune disorders. For additional information about Emergent BioSolutions, visit the company’s Web site at www.emergentbiosolutions.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: